Short ragweed pollen allergen extract (ALK-Abello)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameShort ragweed pollen allergen extract (ALK-Abello)
Drug Alias NameRagweed AIT (ALK-Abello)短豚草花粉过敏原提取物 (ALK-Abello)SLITone ULTRA 302 Ragweed Anfangsbeh (ALK-Abello)豚草过敏疫苗 (ALK-Abello)Ragweed allergy immunotherapy (ALK-Abello) +[12] 
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAllergic asthmaHypersensitivityConjunctivitis +[6] 
Global Approved IndicationsRhinitis, Allergic, Seasonal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date2012/01/01
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAlk-Abello Sa
China Registration ClassN/A

Develop Information

Active CompaniesAlk-Abello Sa
Inactive CompaniesAlk-Abelló A/S
Active IndicationsRhinitis, Allergic, Seasonal
Inactive IndicationsAllergic asthmaHypersensitivityConjunctivitis +[5] 

Other Information

ATC CodeV01AA02
Related LinksN/A